Bristol-Myers Squibb released their earnings last week. No real news on the Abilify front. It continues to grow year over year and now has the pediatric bipolar and adolescent schizophrenia indications in its pocket to be the kid-friendly atypical anti-psychotic. Analysts didn't really press on Abilify since the Mead Johnson IPO idea started all their wheels turning.
Guess we can look for the Abilify reps in our pediatrician's office the next time the kids' need a sports physical.
Sunday, April 27, 2008
Abilify for the Kids
Subscribe to:
Post Comments (Atom)
1 comment:
When I was in high school I was put on Abilify for generalized anxiety disorder. I got terrible akathisia from it. I was put on Risperdal in middle school for a short time and it was weird. Kids have been put on antipsychotics for off label use for years. The drugs really sucked. Lots of middle school teenagers were put on antipsychotics for ocd, generalized anxiety disorder, depression, adhd and hyperactivity and it sucks.
Post a Comment